NEW YORK (GenomeWeb News) – Sony DADC and Anagnostics last week announced a collaboration to develop Anagnostics' hybcell tests.
Sony will initially be in charge of the die-casting of plastic parts and their functional coating "with the objective of enhancing the performance of the components," the two companies said in a joint statement. They added that the co-development of the hybcell tests will improve the tests' effectiveness and "advance the integration and automation of their production."
Financial and other terms of the deal were not disclosed.
Based in St. Valentin, Austria, Anagnostics develops tests and systems aimed at the pharmaceutical and clinical diagnostics spaces. Its hybcell tests use DNA or protein microarrays based on cylinders rather than slides. According to its website, the technology offers minimum hands-on time, ease of use, and fast and comprehensive results.
The hybcell tests are for use on the company's hyborg analysis platform
Last month, Anagnostics announced a deal with Italian firm Cell.ENG for Anagnostics' KRAS mutation test.